Health
FDA support advances biomarker for earlier, more precise Parkinson's clinical trials
Headline as filed by Medical Xpress. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, Medical Xpress, has reported this so far, at 13:40 UTC on 26 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
Medical Xpress
FDA support advances biomarker for earlier, more precise Parkinson's clinical trials
The Critical Path Institute (C-Path) has published "Regulatory endorsement for the application of alpha-synuclein seed amplification assay (αSyn-SAA) as a susceptibility and risk biomarker for clinica
Read on Medical Xpress →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.